NASDAQ
Neumora Therapeutics, Inc. Common Stock (NMRA) has a fcf yield of -70.59% as of Tuesday, August 4, 2026. This represents a 1046.63% decrease compared to its 12-month average of -6.16%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.